Reportedly, SCLC patients with PNSs exhibit a "hot" TME marked by increased TILs, elevated PD-L1 expression, and increased PD-1/PD-L1 interactions, suggesting that such patients may represent an ideal population for receiving ICIs [178]. The gene discussed is PDCD1; the disease is small cell lung carcinoma.